Cannabinoids in Epilepsy at DFTB17

Uncategorized
Shares
Cite this article as:
DFTB, T. Cannabinoids in Epilepsy at DFTB17, Don't Forget the Bubbles, 2018. Available at:
http://doi.org/10.31440/DFTB.16227

This talk was recorded live on the final day of DFTB17 in Brisbane. If you missed out in 2017 then why not book your leave for 2018 now. There are still some tickets available for the pre-conference workshops as well as the conference itself via www.dftb18.com.

John Lawson is a paediatric neurologist at Sydney Children’s Hospital in Randwick. He has been Lead Investigator in the NSW Medical Cannabis in Epilepsy trial and is one of Australia’s leading experts on its use in near intractable seizures.

This is an almost evidence-free zone as the popular press has taken up the fight on behalf of patients.

So what are doctors to do, when parents come to them asking them to prescribe cannabis to their one year old child? This is not a talk about the wholesale legalisation of marijuana but about how, once again, we need to take a closer look at the evidence.

 


This double-blinded, placebo controlled trial reported in last years NEJM sets the scene for the the potential beneficial effects of cannabidiols.

Go ahead and watch the talk…

 

 

You can read this latest paper, a narrative review of some of the challenges facing the use of medical cannabis in the Medical Journal of Australia.

Chen KA, Farrar MA, Cardamone M, Lawson JA. Cannabis for paediatric epilepsy: challenges and conundrums. The Medical Journal of Australia. 2018 Feb 19;208(3):132-6.

Print Friendly, PDF & Email

About 

Someone has to do the work around here and who better than the DFTB house-elves .

Author: Team DFTB Someone has to do the work around here and who better than the DFTB house-elves .

Leave a Reply